Nelarabine is an antineoplastic drug that is used to treat acute T-cell lymphoblastic leukemia. It inhibits DNA synthesis and causes cytotoxicity, and when added to standard chemotherapy, it enhances survival chances for children and young adults diagnosed with T-cell acute lymphoblastic leukemia (T-ALL). In a clinical trial, 89% of patients with T-ALL with moderate to high risk of cancer...